Chawanee Thongpanchang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chawanee Thongpanchang has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
Jittra Kornsakulkarn
National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), 111 Thailand Science Park, Phahonyothin Road, Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand
10 shared publicationsSiriporn Saepua
National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), 111 Thailand Science Park, Phahonyothin Road, Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand
6 shared publicationsPatchanee Auncharoen
National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), 111 Thailand Science Park, Phahonyothin Road, Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand
5 shared publicationsThitiya Boonpratuang
5 shared publicationsWilunda Choowong
National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), 111 Thailand Science Park, Phahonyothin Road, Klong Luang, Pathumthani 12120, Thailand
5 shared publicationsMasahiko Isaka
4 shared publications
Latest Publications
- Open Access
- 18 July 2026
- Published by Elsevier in SSRN Electronic Journal
Ganoboninones J–P, highly oxygenated and modified lanostanes from cultivated fruiting bodies of Ganoderma cf. hochiminhense
Seven previously undescribed highly oxygenated lanostanes, ganoboninones J–P (1–7), were isolated from MeOH extract of cultivated fruiting bodies of Ganoderma cf. hochiminhense (strain TBRC-BCC 22084). Five known lanostanes (8–12) and a meroterpenoid, ganomycin I (13), were also isolated. Ganoboninoes J–M (1–4) are highly rearranged 27-nor-lanostanes possessing an unknown cyclopropane-fused carbon skeleton. Among these, ganomycin I (13) showed antioxidant activity in the DPPH radical scavenging assay with an IC value of 33.8 M (11.6 mg/mL), therefore, it was identified as a key antioxidant constituent of the mushroom MeOH extract (IC50 64.5 mg/mL). Ganoboninones K (2) and P (7) exhibited antitubercular activity against Mycobacterium tuberculosis H37Ra (MIC 25 mg/mL). On the other hand, ganoboninone N (5) and ganomycin I showed selective cytotoxicity to NCI-H187 cells (IC50 13.6 and 5.72 mM, respectively)
- 18 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessGanoboninones J–P, highly oxygenated and modified lanostanes from cultivated fruiting bodies of Ganoderma cf. hochiminhense
Seven previously undescribed highly oxygenated lanostanes, ganoboninones J–P (1–7), were isolated from MeOH extract of cultivated fruiting bodies of Ganoderma cf. hochiminhense (strain TBRC-BCC 22084). Five known lanostanes (8–12) and a meroterpenoid, ganomycin I (13), were also isolated. Ganoboninoes J–M (1–4) are highly rearranged 27-nor-lanostanes possessing an unknown cyclopropane-fused carbon skeleton. Among these, ganomycin I (13) showed antioxidant activity in the DPPH radical scavenging assay with an IC value of 33.8 M (11.6 mg/mL), therefore, it was identified as a key antioxidant constituent of the mushroom MeOH extract (IC50 64.5 mg/mL). Ganoboninones K (2) and P (7) exhibited antitubercular activity against Mycobacterium tuberculosis H37Ra (MIC 25 mg/mL). On the other hand, ganoboninone N (5) and ganomycin I showed selective cytotoxicity to NCI-H187 cells (IC50 13.6 and 5.72 mM, respectively)
- Open Access
- 16 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (5) , 3868-3879
Bioactive metabolites from cultures of the entomopathogenic fungus Pleurocordyceps ophiocordycipiticola TBRC-BCC 9612
Seven new metabolites were isolated from Pleurocordyceps ophiocordycipiticola . Structural elucidation and bioassays revealed ergot alkaloids and tetramic acid derivatives with antimalarial, antibacterial, antifungal, and cytotoxic activities.
- 16 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (5) , 3868-3879
Open AccessBioactive metabolites from cultures of the entomopathogenic fungus Pleurocordyceps ophiocordycipiticola TBRC-BCC 9612
Seven new metabolites were isolated from Pleurocordyceps ophiocordycipiticola . Structural elucidation and bioassays revealed ergot alkaloids and tetramic acid derivatives with antimalarial, antibacterial, antifungal, and cytotoxic activities.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
Chemoselective derivatization of the potent antimalarial fungal metabolite 9-methoxystrobilurin G
A chemoselective semisynthetic strategy was established to modify the C9 and C2 ' positions of 9-methoxystrobilurin G, enabling efficient access to a diverse library of novel derivatives and the evaluation of their antimalarial activities.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
Chemoselective derivatization of the potent antimalarial fungal metabolite 9-methoxystrobilurin G
A chemoselective semisynthetic strategy was established to modify the C9 and C2 ' positions of 9-methoxystrobilurin G, enabling efficient access to a diverse library of novel derivatives and the evaluation of their antimalarial activities.
- Open Access
- 13 February 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (7) , 5234-5241
Bioactive polyketides from cultures of the entomopathogenic fungus Hypocrella luteola TBRC-BCC 76666
Six new polyketides (1–6) and two new naturally occurring compounds (7–8), along with seven known compounds, were isolated from the culture extracts of the entomopathogenic fungus Hypocrella luteola strain TBRC-BCC 76666.
- 13 February 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (7) , 5234-5241
Open AccessBioactive polyketides from cultures of the entomopathogenic fungus Hypocrella luteola TBRC-BCC 76666
Six new polyketides (1–6) and two new naturally occurring compounds (7–8), along with seven known compounds, were isolated from the culture extracts of the entomopathogenic fungus Hypocrella luteola strain TBRC-BCC 76666.
- 6 December 2024
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 20 (3) , e202401134
From Batch to Continuous Flow Synthesis in Enzymatic Process Towards Molnupiravir
Molnupiravir (1) is one among the limited therapeutic options for treating COVID‐19 infection and exhibits pan‐antiviral potency. Because of urgent demands during the COVID‐19 pandemic, a number of methods were developed to offer more efficient routes. In this report, we present a facile 2‐step and scalable synthesis of molnupiravir for batch processing and show the implementation of continuous flow biocatalysis to improve the efficiency in synthesis. Our key step entails immobilized lipase and isobutyric anhydride to facilitate regioselective esterification. In batch process, transamination of cytidine (2) provides N4‐hydroxycytidine (NHC, 3) with 75 % yield followed by esterification of NHC to give molnupiravir with 64 % yield, providing 48 % overall yield and 99.98 % purity (HPLC). Compared to batch approach in the esterification step, the continuous flow process provides similar product yield and purity and highlights the advantages including 2.42‐fold better productivity (mol/day), 2.47‐fold improved reaction time, and 30‐fold higher space‐time‐yield. The optimized batch and continuous flow biocatalysis enhance synthesis efficiency and reduce environmental impact, offering a sustainable approach for industrial molnupiravir production.
- 6 December 2024
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 20 (3) , e202401134
From Batch to Continuous Flow Synthesis in Enzymatic Process Towards Molnupiravir
Molnupiravir (1) is one among the limited therapeutic options for treating COVID‐19 infection and exhibits pan‐antiviral potency. Because of urgent demands during the COVID‐19 pandemic, a number of methods were developed to offer more efficient routes. In this report, we present a facile 2‐step and scalable synthesis of molnupiravir for batch processing and show the implementation of continuous flow biocatalysis to improve the efficiency in synthesis. Our key step entails immobilized lipase and isobutyric anhydride to facilitate regioselective esterification. In batch process, transamination of cytidine (2) provides N4‐hydroxycytidine (NHC, 3) with 75 % yield followed by esterification of NHC to give molnupiravir with 64 % yield, providing 48 % overall yield and 99.98 % purity (HPLC). Compared to batch approach in the esterification step, the continuous flow process provides similar product yield and purity and highlights the advantages including 2.42‐fold better productivity (mol/day), 2.47‐fold improved reaction time, and 30‐fold higher space‐time‐yield. The optimized batch and continuous flow biocatalysis enhance synthesis efficiency and reduce environmental impact, offering a sustainable approach for industrial molnupiravir production.
- 5 February 2024
- Published by Elsevier in Phytochemistry Letters
- Vol. 60, 90-95
Ergostane triterpenoids from cultures of basidiomycete Favolaschia minutissima
- 5 February 2024
- Published by Elsevier in Phytochemistry Letters
- Vol. 60, 90-95
Ergostane triterpenoids from cultures of basidiomycete Favolaschia minutissima
- 26 January 2024
- Published by Elsevier in Tetrahedron
- Vol. 153
Antimalarial (9Z)-9-methoxystrobilurins from cultures of Basidiomycete Favolaschia xtbgensis TBRC-BCC 18687
- 26 January 2024
- Published by Elsevier in Tetrahedron
- Vol. 153
Antimalarial (9Z)-9-methoxystrobilurins from cultures of Basidiomycete Favolaschia xtbgensis TBRC-BCC 18687
- 21 September 2023
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (39) , 7944-7953
Oudemansin and 9-methoxystrobilurin derivatives with antimalarial activity from cultures of the basidiomycete Favolaschia minutissima : assignments of the absolute configurations of the isoprene-derived units
Oudemansin and 9-methoxystrobilurin derivatives with potent antimalarial activity were isolated from cultures of the basidiomycete Favolaschia minutissima . A method for semisynthetic modification was demonstrated.
- 21 September 2023
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (39) , 7944-7953
Oudemansin and 9-methoxystrobilurin derivatives with antimalarial activity from cultures of the basidiomycete Favolaschia minutissima : assignments of the absolute configurations of the isoprene-derived units
Oudemansin and 9-methoxystrobilurin derivatives with potent antimalarial activity were isolated from cultures of the basidiomycete Favolaschia minutissima . A method for semisynthetic modification was demonstrated.
- 24 July 2023
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 14 (9) , 1755-1766
Discovery of rigid biphenyl Plasmodium falciparum DHFR inhibitors using a fragment linking strategy
The screen of a fragment library identified hydrophobic fragments binding to drug resistant PfDHFR active site. Lead design using fragment-linking strategy yielded compounds with nM antimalarial activity, no cytotoxicity and drug-like properties.
- 24 July 2023
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 14 (9) , 1755-1766
Discovery of rigid biphenyl Plasmodium falciparum DHFR inhibitors using a fragment linking strategy
The screen of a fragment library identified hydrophobic fragments binding to drug resistant PfDHFR active site. Lead design using fragment-linking strategy yielded compounds with nM antimalarial activity, no cytotoxicity and drug-like properties.
- 11 April 2023
- Published by Taylor & Francis in Natural Product Research
- Vol. 38 (15) , 2644-2652
Lanostane triterpenoids from artificially cultivated fruiting bodies of Ganoderma cf. mastoporum
In the quest for bioactive compounds from Ganoderma, artificially cultivated fruiting bodies of Ganoderma cf. mastoporum, strain TBRC-BCC 47851 were chemically investigated. The study led to the isolation of three undescribed lanostane triterpenoids (1–3) together with twelve known compounds. The structures were elucidated on the basis of NMR spectroscopic and mass spectrometry data. The new compounds were inactive in the antimalarial and antitubercular activity assays. Graphical Abstract
- 11 April 2023
- Published by Taylor & Francis in Natural Product Research
- Vol. 38 (15) , 2644-2652
Lanostane triterpenoids from artificially cultivated fruiting bodies of Ganoderma cf. mastoporum
In the quest for bioactive compounds from Ganoderma, artificially cultivated fruiting bodies of Ganoderma cf. mastoporum, strain TBRC-BCC 47851 were chemically investigated. The study led to the isolation of three undescribed lanostane triterpenoids (1–3) together with twelve known compounds. The structures were elucidated on the basis of NMR spectroscopic and mass spectrometry data. The new compounds were inactive in the antimalarial and antitubercular activity assays. Graphical Abstract